HAVCR2 and Miyoshi myopathy: Galectin-9 and a proliferation-inducing ligand (APRIL) derived from osteoclasts, which constitute the microenvironment of myeloma cells, induce Tim-3 and programmed death-ligand 1 (PD-L1) on MM cells, respectively, and contribute to immune escape [27].